Calidi Biotherapeutics

CLDI

Börsenwert 2,16 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Geode Capital Management Boston, Massachusetts	19.473 $	+10.407 $	+3.220	+82 %
2	2 HighTower Advisors Chicago, Illinois	14.199 $	–	–	–
3	3 Jane Street New York	9.227 $	+3.933 $	+1.217	+56 %
4	4 Independent Advisor Alliance Charlotte, North Carolina	7.650 $	+9.091 $	+2.813	Neu
5	RCI 5 RS Crum Inc Newport Beach, California	7.351 $	+601 $	+186	+7 %
6	6 Arax Advisory Partners Denver, Colorado	6.349 $	–	–	–
7	7 Private Advisor Group Morristown, New Jersey	5.100 $	+6.060 $	+1.875	Neu
8	8 Vanguard Capital Management Malvern, Pennsylvania	4.337 $	–	–	–
9	9 Belpointe Asset Management Reno, Nevada	3.387 $	–	–	–
10	10 Northern Trust Chicago, Illinois	3.019 $	–	–	–
11	11 Morgan Stanley New York	2.251 $	+763 $	+236	+40 %
12	12 RFG Advisory Birmingham, Alabama	2.040 $	+2.424 $	+750	Neu
13	13 Farther Finance Advisors San Francisco, California	1.700 $	–	–	–
14	14 UBS Group Zurich, Switzerland	1.340 $	+1.593 $	+493	Neu
15	15 Citigroup New York	781 $	+924 $	+286	+28.600 %
16	16 Osaic Holdings Scottsdale, Arizona	450 $	+110 $	+34	+26 %
17	17 Tower Research Capital (TRC) New York	237 $	–	–	–
18	FC 18 Finepoint Capital Boston, Massachusetts	177 $	–	–	–
19	19 Highbridge Capital Management New York	177 $	–	–	–
20	20 SBI Securities Tokyo, Japan	64 $	+52 $	+16	+229 %
21	TCM 21 Tradewinds Capital Management Bellingham, Washington	18 $	–	–	–
22	RFA 22 Reyes Financial Architecture San Diego, California	17 $	–	–	–
23	23 Evermay Wealth Management Arlington, Virginia	1 $	–	–	–
24	24 Armistice Capital New York	–	-209.905 $	-54.938	Geschlossen
25	SM 25 Sabby Management Miami Beach, Florida	–	-103.855 $	-27.181	Geschlossen

Calidi Biotherapeutics CLDI Börsenwert 2,16 Mio. $

Calidi Biotherapeutics

CLDI

Börsenwert 2,16 Mio. $